Page 104 - AIH-2-2
P. 104

Artificial Intelligence in Health                                         Cirrhosis prediction in hepatitis C



            Consent for publication                               models in predicting development of hepatocellular
                                                                  carcinoma. Am J Gastroenterol. 2013;108(11):1723-1730.
            Not applicable.
                                                                  doi: 10.1038/ajg.2013.332
            Availability of data                               6.   Chen YW, Luo J, Dong C, et al. Computer-aided diagnosis

            These analyses were performed using data from the     and quantification of cirrhotic livers based on morphological
            Corporate Warehouse Domains that are available only   analysis and machine learning. Comput Math Methods Med.
                                                                  2013;2013:264809.
            within the U.S. Department of Veterans Affairs firewall
            in a secure research environment, the VA Informatics      doi: 10.1155/2013/264809
            and Computing Infrastructure (VINCI). To comply with   7.   Konerman MA, Zhang Y, Zhu J,  et al. Improvement of
            VA privacy and data security policies and regulatory   predictive models of risk of disease progression in chronic
            constraints, only aggregate summary statistics and results   hepatitis C by incorporating longitudinal data. Hepatology.
            of our analyses are permitted to be removed from the data   2015;61:1832-1841.
            warehouse for publication. The authors have provided      doi: 10.1002/hep.27750
            detailed results of the analyses in the paper. These
            restrictions are in place to maintain veteran privacy and   8.   Weerakody PB, Wong KW, Wang G, Ela W. A  review of
            confidentiality. Access to these data can be granted to   irregular  time  series  data  handling  with  gated  recurrent
                                                                  neural networks. Neurocomputing. 2021;441:161-178.
            persons who are not employees of the VA; however, there
            is an official protocol that must be followed for doing so.      doi: 10.1016/j.neucom.2021.02.046
            The authors also confirm that VA policies are currently   9.   Veterans Health Administration. Available from: https://
            being developed that should allow an interested researcher   www.va.gov/health [Last accessed on 2024 Dec 22].
            to obtain a de-identified, raw dataset upon request with a   10.  Corporate Data Warenouse (CDW): US Department of
            data use agreement. Those wishing to access the data that   Veterans Affairs. Available from: https://www.hsrd.research.
            were used for this analysis may contact Jennifer Burns,   va.gov/for_researchers/vinci/cdw.cfm [Last accessed on
            MHSA, who is a senior data manager at the VA Center for   2014 Mar 28].
            Clinical Management Research, to discuss the details of the
            VA data access approval process. Her contact information   11.  Oliveira AC, El-Bacha I, Vianna MV, Parise ER. Utility and
                                                                  limitations of APRI and FIB4 to predict staging in a cohort
            is as follows: Jennifer.Burns@va.gov; UM North Campus   of nonselected outpatients with hepatitis C.  Ann Hepatol.
            Research Complex, Department of Veterans Affairs, 2800   2016;15(3):326-332.
            Plymouth Road Bldg 16, Ann Arbor, MI.
                                                                  doi: 10.5604/16652681.1198801
            References                                         12.  Lin ZH, Xin YN, Dong QJ, et al. Performance of the aspartate

            1.   Zeremski M, Dimova RB, Pillardy J, de Jong YP,   aminotransferase-to-platelet ratio index for the staging
               Jacobson IM, Talal AH. Fibrosis progression in patients   of hepatitis C-related fibrosis: An updated meta-analysis.
               with  chronic  hepatitis  C  virus  infection.  J  Infect Dis.   Hepatology. 2011;53(3):726-736.
               2016;214(8):1164-1170.                             doi: 10.1002/hep.24105
               doi: 10.1093/infdis/jiw332                      13.  Ioannou GN, Tang W, Beste LA,  et al. Assessment of a
            2.   Freeman AJ, Law MG, Kadlor JM, Dore GJ. Predicting   deep learning model to predict hepatocellular carcinoma
               progression to cirrhosis in chronic hepatitis C virus   in patients with hepatitis C cirrhosis.  JAMA  Netw Open.
               infection. J Infect Dis. 2003;10(4):285-293.       2020;3(9):e2015626.
               doi: 10.1046/j.1365-2893.2003.00436.x              doi: 10.1001/jamanetworkopen.2020.15626
            3.   Waljee AK,  Higgins PD.  Machine  learning in   14.  Chung, J, Gulcehre, C, Cho KH, Bengio Y. Empirical
               medicine:  A  primer  for  physicians.  Am J Gastroenterol.   evaluation of gated recurrent neural networks on sequence
               2010;105(6):1224-1226.                             modeling. arXiv. Preprint posted online 2014.
               doi: 10.1038/ajg.2010.173                          doi: 10.48550/arXiv.1412.3555
            4.   Konerman MA, Beste LA, Van T, et al. Machine learning   15.  Kingma DP, Ba J. Adam: A  method for stochastic
               models to predict disease progression among veterans with   optimization. arXiv. Preprint posted online 2014.
               hepatitis C virus. PLoS One. 2019;14(1):e0208141.     doi: 10.48550/arXiv.1412.6980
               doi: 10.1371/journal.pone.0208141
                                                               16.  Srivastava N, Hinton G, Krizhevsky A, Sutskever  I,
            5.   Singal  AG, Mukherjee A,  Elmunzer  BJ,  et al. Machine   Salakhutdinov  R.  Dropout:  A  simple  way  to  prevent
               learning algorithms outperform conventional regression   neural networks from overfitting.  J  Mach Learn Res.


            Volume 2 Issue 2 (2025)                         98                               doi: 10.36922/aih.4671
   99   100   101   102   103   104   105   106   107   108   109